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A B S T R A C T
IFNγ is a key regulator of inﬂammatory responses but its role in inﬂuenza A virus (IAV) pathogenesis is unclear.
Our studies show that infection of mice lacking the IFNγ receptor (IFNγR-/-) at a dose which caused severe
disease in wild type 129 Sv/Ev (WT) mice resulted in milder clinical symptoms and signiﬁcantly lower lung virus
titers by 6 days post-infection (dpi). Viral spread was reduced in IFNγR-/- lungs at 2 and 4 dpi. Levels of in-
ﬂammatory cytokines and chemokines were lower in IFNγR-/- mice at 2 dpi and there was less inﬁltration of
monocyte/macrophage lineage cells than in WT mice. There was no diﬀerence in CD4+ and CD8+ T cells and
alveolar macrophages in the bronchoalveolar lavage ﬂuid (BALF) at 2 and 4 dpi but by 4 dpi IFNγR-/- mice had
signiﬁcantly higher percentages of neutrophils. Our data strongly suggest that IAV can use the inﬂammatory
response to promote viral spread.
1. Introduction
Inﬂuenza A virus (IAV) infection leads to an inﬂammatory response
characterized by the initiation of an antiviral interferon response and
the release of inﬂammatory mediators which signal leukocyte recruit-
ment to the infected site. Immune cell inﬁltration is crucial for control
of virus replication and resolution of infection. However, this response
often contributes to pathogenesis and morbidity and, in the case of
highly pathogenic IAVs such as the 1918 H1N1 pandemic strain and the
recent avian H5N1 and H7N9 strains, an excessive inﬂammatory re-
sponse (Chen et al., 2013; Perrone et al., 2008; Tumpey et al., 2005) can
cause irreparable damage to the lungs resulting in high mortality rates
(To et al., 2001).
IFNγ is a major driver of inﬂammatory responses. It is produced by
many diﬀerent cell types including NK, NK T cells, macrophages and T
cells and coordinates a broad range of biological activities (Akdis et al.,
2011). A major role of IFNγ is activation of a classical pro-inﬂammatory
macrophage response characterized by secretion of inﬂammatory cy-
tokines such as TNFα and the production of chemokines CCL2 and CCL3
which lead to recruitment of monocytes. IFNγ also induces synthesis of
the chemokines CXCL9 and CXCL10 which recruit T cells to sites of
infection (Taub et al., 1993) and has a major role in linking the innate
and adaptive immune responses. Given the role of IFNγ in driving in-
ﬂammation, we hypothesized that it would contribute to the excessive
inﬂammatory response associated with severe IAV infections. Sup-
porting this hypothesis, our in vitro studies on bone marrow-derived
macrophages (BMDMs) showed that WT BMDMs activated with IFNγ
produced signiﬁcantly higher levels of pro-inﬂammatory cytokines that
IFNγR-/- BMDMs following infection with IAV suggesting a potential
impact on IAV infection in vivo (Campbell et al., 2015).
A number of studies have used mice lacking the IFNγ receptor or in
which IFNγ is depleted by antibody to look at the role of IFNγ in IAV
infections. Whilst there are diﬀerences in T cell responses in primary
(Turner et al., 2007) and secondary infections (Bot et al., 1998) in the
absence of an IFNγ response, most studies have concluded that IFNγ
does not have a signiﬁcant impact on the outcome of IAV infection
(Baumgarth and Kelso, 1996; Graham et al., 1993; Turner et al., 2007).
However, decreased cellular inﬁltration was noted in the lungs of IFNγ
depleted mice infected with an H3N1 reassortant virus (Baumgarth and
Kelso, 1996; Turner et al., 2007). More recently, Califano et al. (2017)
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showed that IFNγ-/- mice infected with the H1N1 pandemic virus A/
California/04/2009 had decreased immunopathology and enhanced
survival, an outcome attributed to suppression of group II innate lym-
phoid cells by IFNγ. It is worth noting that diﬀerences in outcome may
be due to use of diﬀerent strains of virus or mouse (Pica et al., 2011;
Srivastava et al., 2009; Trammell et al., 2012) and that the dose of virus
delivered can aﬀect the activation of the immune response (Pang et al.,
2013). Together, these factors can alter the inﬂammatory response and
subsequent immunopathology, making the overall eﬀect of IFNγ in IAV
infection diﬃcult to interpret.
In this study, infection of WT or IFNγR-/- mice with the H1N1 virus
A/WSN/33 demonstrated that lack of IFNγ signaling resulted in more
rapid control of virus replication and reduced disease symptoms in a
dose dependent manner. IFNγR-/- mice had attenuated viral spread
within the lungs and a lowered inﬂammatory response, in particular
reduced inﬁltration of monocyte/macrophage lineage cells correlating
with the lack of IFNγ response. Together, our data demonstrate that
IFNγ-dependent promotion of the classical inﬂammatory response en-
hances IAV spread thus promoting infection.
2. Materials and methods
2.1. Mouse model of inﬂuenza A virus infection
129 Sv/Ev (WT) mice and IFNγR-/- mice on the 129 Sv/Ev back-
ground (Huang et al., 1993) were purchased from B&K Universal and
bred in-house. WT and IFNγR-/- mice expressing enhanced green
ﬂuorescent protein (EGFP) under control of the Csfr1 promoter, herein
referred to as MacGreen, were derived by crossing MacGreen mice on
the C57BL/6 background (Sasmono et al., 2003) with WT and IFNγR-/-
mice and then back-crossing MacGreen oﬀspring at least seven times
with WT and IFNγR-/- mice. MacGreen animals were maintained as
heterozygous for the EGFP reporter and homozygous for the IFNγ re-
ceptor deletion. All animal work was carried out under the authority of
a UK Home Oﬃce Project Licence within the terms and conditions of
the UK Home Oﬃce “Animals (Scientiﬁc Procedures) Act 1986” and
subject to local ethical review. Appropriate numbers of animals (sample
size) were determined using formal power analysis, based on pilot in
vivo experiments. Predicted outcomes and variation in assay techniques
were used to determine the power of the experiment, allowing for
statistical judgements that are accurate and reliable and responsible
hypothesis testing. Six- to 8-week-old female mice were used in all
experiments. Mice were anesthetized using isoﬂurane (Merial, Boeh-
ringer Ingelheim Animal Health, UK) and infected intranasally with 104
pfu H1N1 A/WSN/33 IAV in 40 µl volume, unless otherwise stated.
Mice were weighed daily and assessed for visual signs of clinical dis-
ease, including inactivity, ruﬄed fur, and laboured breathing. At var-
ious times after infection, mice were euthanized by CO2 asphyxiation,
and tissues collected. By 8 dpi, WT animals had lost 25–30% of their
original body weight and were euthanized for humane reasons. No
IFNγR-/- mice lost more than 11% body weight.
2.2. Cells and virus
Madin Darby canine kidney epithelial cells (MDCK, ATCC), were
maintained in Dulbecco's modiﬁed Eagle's medium (ThermoFisher
Scientiﬁc UK) supplemented with 10% fetal bovine serum
(ThermoFisher Scientiﬁc UK), 50 U/ml penicillin and 50 µg/ml strep-
tomycin (Thermoﬁsher Scientiﬁc, UK). Inﬂuenza A virus strain A/WSN/
33 was obtained from Dr D Jackson, University of St Andrews. Virus
was propagated in MDCK cells and titered by standard plaque assays as
previously described (Nicol et al., 2012).
2.3. Histopathology
Lungs were inﬂation-ﬁxed with neutral buﬀered formalin,
embedded in paraﬃn, processed to 10 µm sections and stained with
hematoxylin and eosin (H&E) using routine methods. Sections were
scored blinded using a semi-quantitative system to examine the fol-
lowing criteria: epithelial and interstitial necrosis, peribronchial in-
ﬂammation, perivascular inﬂammation, interstitial inﬂammation and,
for day 8, perivascular and peribronchial oedema, using a score varying
from 0 to 3. Scores were calculated from the sum of the scores for the
ﬁve individual criteria determined for each mouse.
2.4. Quantitation of virus spread
Paraﬃn embedded sections were deparaﬃnized, rehydrated in
graded alcohol solutions to water, followed by heat-induced antigen
retrieval in Tris/EDTA pH 9.0 buﬀer. IAV was detected using a poly-
clonal goat anti-inﬂuenza A virus antibody (USSR (H1N1), AbD
Serotec). Endogenous peroxidase was blocked with 3% hydrogen per-
oxide, followed by secondary antibody donkey anti-goat HRP (AbD
Serotec) and DAB chromogen staining (SIGMAFastTM 3,3′-DAB tablets,
Sigma-Aldrich, UK). Tissue was counterstained with haematoxylin,
blued with Scott's tap water, rinsed in water, dehydrated through
graded alcohols, cleared and mounted with Mowiol. DAB stained sec-
tions were used to map sites of active virus infection within lung sec-
tions using NanoZoomer Digital Pathology Viewing software
(NDP.view, Hamamatsu). Area (µm2) of infection and total lung area
were exported to and analysed by Excel.
2.5. Quantitation of monocyte/macrophage inﬁltration
MacGreen WT and IFNγR-/- lungs were inﬂation-ﬁxed with 4%
paraformaldehyde for 4 h, followed by 24 h in 18% (w/v) sucrose and
mounted with Tissue-Tek OCT medium in isopentane cooled over dry
ice. Frozen sections were cut at 8–10 µm using a cryostat, air dried and
stored at −70 °C. Sections were air dried, blocked with CAS block
(Invitrogen) and stained with goat anti-GFP (AHP975; AbD Serotec,
UK) followed by anti-goat Alexa Fluor-488 (Invitrogen). Cells were
counterstained with DAPI to visualize nuclei and mounted with
ProLong Gold (Invitrogen). Sections were analysed using Leica DMLB,
Zeiss LSMpascal confocal microscopy and ImageJ software.
2.6. Bronchoalveolar lavage ﬂuid (BALF) preparation and ﬂow cytometry
analysis
BALF was collected from control and IAV infected WT and IFNγR-/-
mice. Lungs were ﬂushed multiple times with 1ml ice-cold sterile HBSS
with 3mM EDTA, pH 7.2. BALF was pooled and maintained on ice until
centrifugation at 350×g for 10min, 4 °C, and treated with red blood
cell lysis buﬀer prior to further analysis. Cells were resuspended in
FACS buﬀer (PBS/FCS) with Fc block (CD16/32, 0.5 mg/ml; BD
Biosciences, UK) and stained for 1 h at 4 °C using the following anti-
bodies: anti-CD11b-APC (M1/70.11.5; Miltenyi Biotec Ltd., UK), anti-
Ly6G-PE/Cy7 (BD Biosciences), anti-CD4-PE (RM4–5; BD Biosciences),
anti-CD8-FITC (53–6.7; BD Biosciences), anti-CD11c-PE/Cy7 (N418;
BioLegend, UK), anti-Siglec-F BV421 (E50–2440; BD Biosciences), and
appropriate isotype/FMO controls. Cell viability was determined using
Zombie ﬁxable dyes during staining to exclude dead cells (Zombie Aqua
or Violet; BioLegend). Cells were ﬁxed with BD Cytoﬁx (BD Biosciences)
and analysed using the BD LSR Fortessa and FlowJo V10 software
(FlowJo LLC, USA) using a gating strategy adapted from Misharin et al.
(2013) (Supplementary Fig. S4).
2.7. Determination of cytokine protein production by array and ELISA
WT and IFNγR-/- mice were challenged with 1×104 PFU A/WSN/
33 inﬂuenza virus and, at appropriate times, lungs were harvested and
homogenised in serum free DMEM medium using the TissueLyser II
system (Qiagen, UK). Lysate was clariﬁed and supernatant was used in
M.Q. Nicol et al. Virology 526 (2019) 155–164
156
the Proteome Proﬁler, mouse cytokine array panel A kit (R&D Systems,
USA), following manufacturer's guidelines, developed with IRDye
800CW Streptavidin and analysed using the LI-COR Odyssey imaging
system (LI-COR, USA) and Image Studio Lite software (LI-COR). ELISAs
were performed on clariﬁed supernatant. IFNβ ELISAs used anti-mouse
IFNβ capture antibody (clone RMMB-1), a rabbit anti-mouse IFNβ de-
tection antibody (R&D Systems), and goat anti-rabbit-HRP (Abcam, UK)
and were developed using DuoSet ancillary substrate reagent pack 2 (R
&D Systems). IFNλ was detected using murine IL-28A/B (IFNλ2/3)
DuoSet ELISA kit and ancillary reagent kit 2, following the manufac-
turer's guidelines (R&D Systems). ELISA optical densities determined
using a microplate reader set at 450 nm, with wavelength correction.
Standard curves were created and four parameter logistic curve-ﬁt
used, and absolute quantities of analytes obtained in pg/ml.
2.8. qRT-PCR
Lungs from WT mice and IFNγR-/- mice were harvested into
RNALater and after 24 h RNA was extracted using RNeasy kits (Qiagen),
with on column DNase treatment (Qiagen). cDNA was synthesized with
SuperScript II RT kit (ThermoFisher Scientiﬁc) and Oligo(dT)15 pri-
mers. qRT-PCR was performed using SYBRGreen I (Biogene) and
FastStart Taq (Roche). Primers for succinate dehydrogenase complex A
(SDHA) and CD206 were as previously described (Campbell et al.,
2015). The speciﬁcity of the amplicons was veriﬁed by melt curve
analysis, and PCR eﬃciencies determined. All primers had an eﬃ-
ciency>95%. The threshold cycles (Ct) were determined in triplicate,
normalized to levels of a constitutive housekeeping gene and used to
obtain the relative levels of genes of interest using the 2-ΔCt method.
Alternatively, absolute copy number was calculated from standard
curves and normalized to levels of expression of the housekeeping gene
SDHA.
2.9. Statistical analyses
All statistical analyses were carried out in R (Version 3.4.2 © 2017 R
Foundation for Statistical Computing). Viral titer data, lung section
areas, protein array, gene expression, IFNγ, IFNλ and gene copy/reac-
tion data were log10 transformed prior to analyses to normalise the
residuals. Back-transformed least square mean ± 95% conﬁdence in-
tervals for summary measures were obtained (not reported). As dif-
ferent experiments had been used to generate the data, where possible
(days 1–4) experiment number was added as a ﬁxed eﬀect in all ana-
lyses. For post day 4, either only a single experiment was carried out, or
only one mouse strain was used in that experiment, so no experiment
eﬀect was added. Statistical signiﬁcance was taken when p was< 0.05.
Diﬀerences in weight, virus load and lung section data on diﬀerent days
post-infection between mouse strains were evaluated with analysis of
variance (ANOVA). Log10 total lung area was added as a covariate in
the analyses of lung section areas. Overall diﬀerences between mouse
strains in protein array and gene expression data were also evaluated
with ANOVA, with two-sample t-tests used to look at individual cyto-
kine and chemokines. For histopathology score data ordinal logistic
regression (OLR) were carried out. Binary logistic regression models
(BLR) were used to evaluate diﬀerences between mouse strains in the
percentage of CD4+ and CD8+ T cells, neutrophils and alveolar mac-
rophages in BALF. Where there was over dispersion in these BLR
models, this was adjusted for by using a ‘quasibinomial’ error structure.
Diﬀerences in gene copies between mouse strains was evaluated using
two-sample t-tests.
3. Results
3.1. Absence of a type II IFN receptor confers resistance to severe inﬂuenza
A virus infection
In order to investigate the role of IFNγ in IAV infection, we infected
WT and IFNγR-/- mice with the H1N1 IAV strain A/WSN/33. Infection
of WT mice resulted in progressive weight loss from 6 days post-in-
fection (Fig. 1A) and an increase in clinical symptoms characterized by
hunching, ruﬄed fur, decreased mobility (data not shown). In contrast,
IFNγR-/- mice had no weight loss at day 6 and lost signiﬁcantly less
weight at 7 and 8 dpi (Fig. 1A, p < 0.001). When virus loads in these
mice were quantiﬁed by plaque assay, there was no diﬀerence in total
lung virus loads at 2 or 4 dpi (p > 0.174) but at 6 and 8 dpi IFNγR-/-
mice had signiﬁcantly less virus (p < 0.002) and by 8 dpi the majority
of animals had cleared the virus (Fig. 1B). These results were highly
reproducible with both clinical signs and virus loads indicating that
IFNγR-/- mice developed disease of reduced severity compared to WT
Fig. 1. IFNγR-/- mice are more resistant to severe IAV infection than wild
type mice. Wild type and IFNγR-/- mice were infected with A/WSN/33 and
monitored daily for weight loss (A); at appropriate time points, lungs were
harvested and assayed for infectious virus (B). Graphs show mean with 95% CI,
data are from 6 experiments in total with between 29 (weight day 0 wild type)
and 6 (days 7–8 IFNγR-/-) mice per time point. Data were analysed by ANOVA,
with experiment added as a ﬁxed eﬀect for days 1–4. ***p < 0.001,
**p < 0.01.
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mice.
3.2. Comparative histopathology of infection in WT and IFNγR-/- mice
To determine whether the enhanced survival of IFNγR-/- mice fol-
lowing IAV infection was associated with decreased pathology, lung H&
E sections were blind scored for evidence of tissue damage (Fig. 2A).
The pathology identiﬁed in the lungs was characterized by mild to se-
vere, focal to coalescing, acute to subacute bronchointerstitial pneu-
monia with epithelial cell necrosis, consistent with infection with in-
ﬂuenza A virus. As expected, the severity of the histopathological
changes increased over time (day 2 < day 4 <day 8). Sections were
scored on a scale of 0–3 for epithelial and interstitial necrosis as well as
peribronchial, perivascular and interstitial inﬂammation
(Supplementary Fig. S1). At 2 and 4 dpi, there were no signiﬁcant
diﬀerences in overall scores between WT and IFNγR-/- mice (p=0.084,
Fig. 2B), however, the IFNγR-/- mice showed a trend towards reduced
levels of epithelial necrosis (days 2 and 4) and interstitial inﬂammation
(day 2) compared to the WT mice (Supplementary Fig. S1). At 8 dpi the
IFNγR-/- mice had fewer clinical symptoms and lower virus loads, but
higher overall pathology scores compared to WT mice (Fig. 2B) due to
increased perivascular and interstitial inﬁltration by neutrophils. In-
terestingly, the extent of necrosis at 8 dpi was similar in both strains
(Supplementary Fig. 1). The increased necrosis and inﬂammation in the
WT mice at early times was identiﬁed as a key ﬁnding, potentially
providing an indicator as to the role played by IFNγ in infection.
3.3. Viral spread is controlled in the lungs of IFNγR-/- mice at early time
points
To determine if the absence of the IFNγR inﬂuenced the spread of
IAV infection in the lungs, lung sections were stained with antibody to
H1N1 virus and examined by microscopy. Low power images (Fig. 3A)
showed that there was less virus antigen in the IFNγR-/- lungs than in
the WT lungs. In order to quantitate this, whole lung sections stained
with antibody to H1N1 and were scanned by NanoZoomer allowing us
to measure the total infected area per lung section. Whole lung section
maps (Fig. 3B) showed that WT mice had a greater overall spread of the
virus than IFNγR-/- mice and more foci of active infection. As there was
some mouse to mouse variation, we quantitated the infected areas and
calculated the percentage of total lung area infection at 2 and 4 dpi
(Fig. 3C). This showed that the IFNγR-/- mice had a signiﬁcantly
(p=0.001) lower mean area of infection than WT mice (Fig. 3C), in-
dicating that spread of infection was already controlled at these early
time points.
3.4. Comparative expression of cytokines and chemokines in IFNγR-/- mice
As type I and type III interferons mediate control of IAV infection
(Crotta et al., 2013), we hypothesized that diﬀerences in type I and/or
type III interferon responses might account for the reduced viral spread
in the lungs of IFNγR-/- mice. However, there was no statistically sig-
niﬁcant diﬀerence between mouse strains observed (p > 0.254) by
ELISAs for IFNβ and IFNλ (Supplementary Fig. S2) or qRT-PCR for IFNβ
and IFNα4 transcripts (Supplementary Fig. S3). This indicated that
control of spread was not likely to be due to diﬀerential expression of
these cytokines early after infection (Supplementary Fig. S3). WT mice
did, however, have greater levels of IFNλ by 6 dpi, though this diﬀer-
ence was not statistically signiﬁcant (Supplementary Fig. S2).
Given the role of IFNγ as a major pro-inﬂammatory mediator, we
asked if there were changes in other cytokines or chemokines which
would allow us to understand how the lack of IFNγ was protective. We
therefore compared expression of pro-inﬂammatory mediators in
IFNγR-/- and WT mice in lung homogenate using protein arrays. A
number of inﬂammatory cytokines, including TNFα, IL-1α, IL-1β, IL-6,
IL-7 and IL-12p70, were elevated in the lungs of WT mice at 2 dpi when
Fig. 2. Histopathological changes within the lungs of wild type and
IFNγR-/- mice infected with IAV. Wild type and IFNγR-/- mice were infected
with IAV A/WSN/33 and, at the indicated times post-infection, mice were eu-
thanized, lungs were inﬂation-ﬁxed and H&E sections were prepared. Sections
were scored blind for epithelial and interstitial necrosis, peribronchial, peri-
vascular and interstitial inﬂammation and perivascular and peribronchial oe-
dema using a score from 0 to 3. (A) Representative H&E sections. Arrow heads
indicate perivascular cuﬃng and these areas are shown at higher magniﬁcation
in the bottom panels. Scale bars are 50 µm, top 4 panels and bottom 2 panels
and 20 µm for day 8 low magniﬁcation. (B). Sum of pathology scores from in-
dividual mice with median. Data represent four independent experiments, with
6–10 mice per time point. *p < 0.05 by ordinal logistic regression, with ex-
periment added as a ﬁxed eﬀect for days 2 and 4.
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compared with IFNγR-/- mice (p < 0.05, Fig. 4A). In contrast, twelve
other inﬂammatory cytokines showed no signiﬁcant diﬀerences be-
tween mouse strains at this early time (Fig. 4A, p > 0.06).
The array analysis revealed higher levels of the chemoattractants
MCP-1 (CCL2), MCP-5 (CCL12), KC (CXCL1), MIP-2 (CXCL2), MIG
(CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) (p < 0.044, Fig. 4B) in
WT mice when compared to IFNγR-/- mice at 2 dpi. Increased
expression of MCP-1 (CCL2), MCP-5 (CCL12), MIG (CXCL9) and I-TAC
(CXCL11) was maintained in WT mice at 6 dpi (p < 0.024) and, in
addition, levels of MIP1α (CCL3), MIP1β (CCL4), RANTES (CCL5) were
elevated at this later time point (Supplementary Fig. S4). Overall, the
expression of inﬂammatory mediators in the IFNγR-/- mice was lower at
2 dpi and by 6 dpi there was further evidence of a greater inﬂammatory
response in the WT mice. The muted inﬂammatory response to IAV
Fig. 3. Virus infection is more widespread in the lungs of wild type mice compared with those of IFNγR-/- mice.Whole lung sections were paraﬃn-embedded,
stained with antibody to H1N1 virus and imaged by light microscopy or scanned for virus antigen using the NanoZoomer Digital Slide Scanner. (A) Representative
lung Section 2 dpi. Arrows indicate virus antigen positive areas. (B) Map of lung sections from individual mice at 2 dpi showing sites of active virus infection. Areas
positive for viral antigen are outlined in black. Images are from four individual mice. Slide bar is 1mm. (C) Virus antigen positive areas at 2 and 4 dpi were
quantitated using NDP.view software (Hamamatsu). Graph shows the percentage of total lung area positive for virus antigens per mouse with median. **p < 0.01,
(taking into account total lung area imaged as a covariate, and experiment as a ﬁxed eﬀect). Data are from two independent experiments, n=4 mice per group, per
experiment.
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Fig. 4. Diﬀerences in cytokine and chemokine expression in wild type and IFNγR-/- mice can be detected two days after infection. Wild type and IFNγR-/-
mice were infected with IAV. Lungs were harvested 2dpi and homogenates were assayed for expression of cytokines (A) or chemokines (B) by protein array. Data
show min/max with median, n=4 mice per group. **p < 0.01, *p < 0.05 by two sample t-tests on log10 transformed data.
M.Q. Nicol et al. Virology 526 (2019) 155–164
160
infection in the IFNγR-/- mice correlates with the lack of clinical
symptoms and decreased weight loss.
3.5. Comparative lung cell populations in WT and IFNγR-/- mice
We next examined whether these altered cytokine and chemokine
proﬁles in IFNγR-/- mice following IAV infection inﬂuenced the lung
cellular environment and whether diﬀerences in immune cell recruit-
ment might account for the diﬀerential control of infection. Flow cy-
tometric analysis demonstrated that the BALF from IAV-infected WT
and IFNγR-/- mice 2 or 4 dpi contained similar percentages of T cells to
the mock-infected mice and, importantly, that percentages of CD4+ T
or CD8+ T cells were similar in both strains (p > 0.422, Fig. 5A, B). By
2 dpi, however, the BALF cell population was comprised of over 20%
CD11b+ Ly6G+ neutrophils. The percentage of neutrophils increased
between 2 and 4 dpi and by 4 dpi there were signiﬁcantly more neu-
trophils in the IFNγR-/- mice (p=0.013, Fig. 5C, gating strategy
Supplementary Fig. S5). Thus, although there was no diﬀerence in T cell
recruitment at early time points, lack of IFNγR resulted in diﬀerences in
the neutrophil percentages.
We next considered whether early clearance of virus in the IFNγR-/-
mice might be related to diﬀerences in lung macrophage populations.
Firstly, we asked if there were diﬀerences in the percentages of alveolar
macrophage (AM) as these are the ﬁrst immune cells which encounter
virus within the lung. We found that percentages of AMs (deﬁned as
CD11b- CD11c+ Siglec-F+, gating strategy Supplementary Fig. S5)
(Misharin et al., 2013) were similar in the lungs of mock-infected and
IAV-infected WT and IFNγR-/- mice at 2 dpi (p < 0.778). By 4 dpi,
however, as has been previously noted for IAV infections (Ghoneim
et al., 2013; LeMessurier et al., 2016), the AM population was severely
depleted in both strains (p < 0.001, Fig. 5D). Thus, there was no ap-
parent signiﬁcant diﬀerence in the percentages of AMs or the kinetics of
AM loss between the WT and IFNγR-/- mice (p=0.062).
Alveolar macrophages, however, represent only one of the lung
macrophage populations. Interstitial macrophages are found within the
lung parenchyma and, in the infected lung, monocytes are recruited and
diﬀerentiate into exudate derived macrophages. In order to look at the
overall macrophage population in the lung, we utilized the MacGreen
mouse model where all cells of macrophage lineage express EGFP
(Sasmono et al., 2003). WT and IFNγR-/- mice were backcrossed with
MacGreen mice and infected with IAV and EGFP expression in lung
sections was visualized and quantitated. Comparison with mock-in-
fected mice demonstrated that there was less recruitment of EGFP po-
sitive cells into the lungs of MacGreen IFNγR-/- mice at 2 dpi, when
compared to the MacGreen WT controls (Fig. 6A, B), a diﬀerence that
was statistically signiﬁcant (p < 0.003). Thus there were signiﬁcant
diﬀerences in both the neutrophil and macrophage populations fol-
lowing IAV infection of IFNγR-/- mice.
4. Discussion
Our in vitro studies on infection of BMDMs showed that IFNγR-/-
macrophages had a muted inﬂammatory response following IAV in-
fection (Campbell et al., 2015). Based on these studies, we set out to
investigate in detail how a deﬁciency in the ability to mount a classical
macrophage response would impact the outcome of infection in vivo by
comparing the kinetics of infection in IFNγR-/- mice with those in WT
mice. Importantly, we used the same strain of virus (A/WSN/33) and
the same genetic background of mice (129 Sv/Ev) as in our in vitro
studies, as both virus strain and mouse genetic background can have a
signiﬁcant eﬀect on the outcome of infection (Pica et al., 2011;
Srivastava et al., 2009; Trammell et al., 2012).
At virus doses that caused severe clinical disease in WT mice,
IFNγR-/- mice were less susceptible to IAV infection. From 2 dpi virus
Fig. 5. Immune cell populations in BALF. Wild type
and IFNγR-/- mice were infected with IAV and BALF
collected at indicated times post-infection. Frequency
of CD4+ T cells (A), CD8+ T cells (B), neutrophils (C),
and alveolar macrophages (AMs) (D) were quantiﬁed
by FACS. CD4+ and CD8+ T cells were detected with
directly conjugated antibodies to CD4 and CD8.
Neutrophils were CD11b+Ly6G+ and AMs were
CD11b-,CD11c+,SiglecF+ populations. Graphs show
individual mice from two independent experiments,
n=2 mice per PBS group and n=4 per virus group.
Bars show mean values. ***p < 0.001, **p < 0.01,
*p < 0.05 by binary logistic regression, with experi-
ment added as a ﬁxed eﬀect for neutrophil and AM
analyses.
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spread was attenuated in IFNγR-/- mice and there was decreased re-
cruitment of monocyte/macrophage lineage cells. Although there was
no diﬀerence in virus titers or clinical signs at early time points (2 and 4
dpi), at later times diﬀerences were found in both parameters. By 8 dpi,
WT mice had severe disease and were culled for humane reasons while
IFNγR-/- animals had fewer clinical signs and weight loss at day 8 and
no signs of infection by day 15 (data not shown).
Our data contrast with other studies which have concluded that
IFNγ plays no role in mouse survival or morbidity and does not aﬀect
virus clearance (Baumgarth and Kelso, 1996; Graham et al., 1993; Price
et al., 2000; Turner et al., 2007). However, as noted above, both virus
and mouse strain can aﬀect outcome. Interestingly, these studies
showed that although IFNγ did not have a major role in the develop-
ment of antibody and/or CD8 T cell responses to IAV infection, there
was reduced cellular inﬁltration in the absence of IFNγ (Baumgarth and
Kelso, 1996; Turner et al., 2007). Our studies also show reduced cel-
lular inﬁltration and explore how events early in infection inﬂuence the
longer term outcome. The data provide new insight into the role of IFNγ
in inﬂammatory cell recruitment and its importance in IAV pathogen-
esis.
The reduced inﬂammatory response in the IFNγR-/- mice could re-
sult from the inability of macrophages and other cells to respond to
IFNγ. Production of pro-inﬂammatory cytokines correlates with clinical
symptoms and weight loss in IAV infection (Cheung et al., 2002; Peiris
et al., 2009) and hence the lack of such symptoms in IFNγR-/- mice
likely reﬂects the lack of pro-inﬂammatory response. Similarly, the
reduced macrophage/monocyte inﬁltration observed 2 dpi correlates
with the lower production of chemokines such as MCP1/CCL2 and
CCL12 both of which are produced by inﬂammatory macrophages and
are chemoattractants for cells of this lineage. Importantly, our ﬁndings
show that an aggressive inﬂammatory response is not essential for
control of infection.
The mechanism by which virus spread is controlled at early times
and how this relates to the decreased lung virus loads at day 6 and more
rapid clearance of the virus remains to be determined. Interplay be-
tween type I and type II interferons has been documented (Stifter et al.,
2016) and we hypothesized that the lack of IFNγ might result in an
enhanced type I or type III IFN response which would account for the
reduced spread of virus at days 2 and 4 and the lower viral load at day
6. However, we could ﬁnd no evidence for elevated levels of IFNβ or
IFNλ in the lungs of IFNγR-/- mice at early time points indicating that
control of infection is unlikely to be due to these cytokines.
T cell responses to IAV infections are detected by 6 dpi and hence it
is also unlikely that enhanced T cell responses account for the decreased
spread at 2 and 4 dpi. In agreement with this, we did not ﬁnd increased
T cell inﬁltration into the BALF of IFNγR-/- mice. Hence it is unlikely
that early recruitment of T cells accounts for the control of virus spread.
In contrast, neutrophil populations were increased in the IFNγR-/-
mice by 2 dpi and by day 4 this was statistically signiﬁcant. At day 8,
neutrophil inﬁltration represented the major component of histo-
pathology in IFNγR-/- mice. Similar increases in neutrophil numbers
have been reported at late time points (day 7) in C57/BL6 IFNγR-/- mice
infected with H1N1 A/PR8/34 (Stifter et al., 2016). Production of
chemokines that drive neutrophil recruitment is stimulated by IL-17
(Linden et al., 2005) which is, in turn, under control of IFNγ (Nandi and
Behar, 2011). In addition, IFNγ directly impairs survival of poly-
morphonuclear cells (Nandi and Behar, 2011), suggesting that, in the
absence of IFNγ, neutrophils are likely to be recruited in higher num-
bers and to survive for longer. Neutrophil inﬁltration has been docu-
mented in animal models of severe IAV infection (Graham et al., 1993;
Hussell et al., 2001; Tate et al., 2010; Taub et al., 1993; To et al., 2001)
and they contribute to pathogenesis in response to other infections.
However, our data indicate that neutrophils are likely to have diverse
roles in IAV pathogenesis, highlighting a potentially important role in
early control of infection. Further studies are required to determine
whether the early increase in neutrophil numbers in the absence of
IFNγR signaling contributes to the control of spread and clearance of
virus and how the high neutrophil numbers at later times relate to virus
pathogenesis.
Macrophages can be infected by IAV and our in vitro studies on
BMDMs showed that alternatively activated BMDMs are more readily
infected and more quickly killed by IAV (Campbell et al., 2015). In-
terestingly, we found that the alternative macrophage marker CD206 is
expressed at signiﬁcantly higher levels in lungs of IFNγR-/- mice
(Supplementary Fig. S6) suggesting that macrophages in the lungs of
these mice have a less pro-inﬂammatory phenotype than WT mice.
CD206 has been shown to be important in virus uptake into macro-
phages (Reading et al., 2000; Upham et al., 2010) and hence, it is
possible that macrophages in IFNγR-/- mice are more readily infected
with IAV and thus act as a “sink” (Nicol and Dutia, 2014; Schneider
et al., 2014) to remove infectious virus. As IAV replicates poorly in
Fig. 6. Decreased inﬁltration of inﬂammatory cells in IFNγR-/- mice. Wild
type MacGreen and IFNγR-/- MacGreen mice were infected with IAV and lung
sections analysed for presence of EGFP expressing cells 2 dpi by staining with
goat anti-GFP followed by Alexa Fluor-488. Cells were counterstained with
DAPI (blue). Ten ﬁelds were imaged for each mouse and the distribution of
green cells blind scored as follows: 0= no green cells; 1= green cells present;
2=moderate focal or multifocal; 3=marked EGFP expression apparent on
majority of area. Graph represents three independent experiments. Solid line
shows median inﬂammatory score. **p < 0.01 from ordinal logistic regression.
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macrophages, this would result in less virus to infect epithelial cells and
thus reduced virus spread in the IFNγR-/- mice. AMs are the ﬁrst mac-
rophages to encounter virus, hence such a scenario might result in more
rapid loss of AMs in IFNγR-/- mice. However, we did not observe dif-
ferences in kinetics of AM loss in WT and IFNγR-/- mice and similar
percentages of AMs were positive for viral antigen 24 h post-infection
(data not shown). Hence, additional studies are needed to determine
whether infection of AMs or other lung macrophage populations con-
tributes to the control of virus spread in IFNγR-/- mice.
The phenotype of AM may aﬀect IAV infection in other ways. AMs
have recently been shown to protect type I alveolar epithelial cells
(AECs) from IAV infection by a previously unrecognized mechanism
which is independent of type I and type II IFN (Cardani et al., 2017).
These studies showed that speciﬁc depletion of AM resulted in en-
hanced viral titers and viral spread and that control of titer and spread
was restored by transfer of AM. Reduced susceptibility was suggested to
be due to suppression of the cysteinyl leukotriene pathway enzymes in
type I AECs. The phenotype of the AM may alter its ability to suppress
this pathway and the alternative phenotype in IFNγR-/- mice might be
more eﬃcient at suppressing viral replication in AECs.
An interesting possibility to consider is that the virus has found
ways to exploit the IFNγ response to enhance infection and hence re-
plication and spread is attenuated in its absence. Such dependence has
been described in Tlr7-/-Mavs-/- mice where infection with sub-lethal
doses of virus leads to lower lung virus titers than in WT mice. In these
knockout mice, there is reduced recruitment of monocytes leading to
lower numbers of infected monocyte derived DCs (Pang et al., 2013)
and the decrease in target cells has been proposed to account for the
decrease in viral titers. Interestingly, this eﬀect is overcome when
Tlr7-/-Mavs-/- mice are infected with higher doses. Similarly, in our
model, the absence of an innate inﬂammatory response protects mice
from lethal infection at lower doses of virus but not at higher doses
(data not shown). We also found decreased recruitment of monocyte
lineage cells and it is possible that a similar mechanism, i.e. reduced
numbers of target cells, is responsible for the control of spread and
lower virus titers. Such dependence on host responses may be crucial in
human infections. Although lack of an IFNγ response is rare in humans,
respiratory diseases or other infections may alter the host's ability to
mount an eﬃcient inﬂammatory response. Our data suggest this may
impact virus ampliﬁcation. This may be particularly important where
the infective dose is low, as may occur in a natural infection, and the
virus must be rapidly ampliﬁed to establish an infection before sec-
ondary immune responses are activated.
In conclusion, our data show that lack of an IFNγ response leads to
an attenuated IAV infection characterized by fewer clinical signs, de-
creased viral titers and a decreased inﬂammatory response including
lower levels of inﬂammatory cytokines/chemokine and less inﬁltration
of monocyte/macrophage lineage cells. Attenuation of infection is de-
pendent on the dose of virus and did not occur when high doses were
used. The data presented here provide evidence that IFNγ responsive-
ness plays a crucial indirect role in early control of virus spread and
shed further light on how the inﬂammatory response is an integral part
of IAV pathogenesis. Understanding the precise mechanisms by which
IAV interacts with the innate immune system, particularly in the con-
text of low, physiological doses of virus will aid in designing new
prophylactic and therapeutic strategies for prevention and control of
IAV infections.
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